In araC-resistant AML, applying AZD4573 and 10058F4 to downregulate c-Myc and Mcl-1 to inhibit Bcl-2 simultaneously and, on the other hand, to induce apoptosis by the activation of the endogenous apoptotic pathway. The gene discussed is BCL2; the disease is acute myeloid leukemia.